| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |